This is the most extensively investigated ERBB2 polymorphism related to cancer risk and is located at codon 655 (ATC/isoleucine to GTC/valine) in the transmembrane domain of the HER2 receptor (exon 17) [75]. The gene discussed is ERBB2; the disease is cancer.